Jennifer Pietenpol
-
Scott Hiebert named Chief Scientific Officer of Cancer Prevention and Research Institute of Texas
Scott Hiebert, Hortense B. Ingram Chair in Cancer Research, has been named Chief Scientific Officer of the Cancer Prevention and Research Institute of Texas. Hiebert served as chair of the National Cancer Advisory Board and brought global recognition to the Vanderbilt-Ingram Cancer Center during his 28 years at Vanderbilt. Read MoreAug. 4, 2025
-
Pietenpol to receive American Society of Clinical Oncology’s highest honor
Jennifer Pietenpol, Executive Vice President for Research and chief scientific and strategy officer for VUMC and professor of biochemistry and otolaryngology, is the 2024 recipient of the Science of Oncology Award, for outstanding contributions to basic or translational research in cancer. She is among a select group of global oncology leaders being recognized with special awards by ASCO and Conquer Cancer, the organization’s foundation. Read MoreApr. 11, 2024
-
Kimberly Newsom in Pietenpol lab honored with Research Staff Award
Laboratory and administrative personnel at Vanderbilt University Medical Center were honored March 4 for research excellence during the 18th annual Research Staff Awards Ceremony at the Aertson Hotel in Nashville. Jennifer Pietenpol, PhD, director of the Vanderbilt-Ingram Cancer Center and VUMC’s Executive Vice President for Research, and Lawrence Marnett, PhD,… Read MoreMar. 10, 2022
-
Pietenpol named chief scientific and strategy officer
Jennifer Pietenpol, PhD, director of the Vanderbilt-Ingram Cancer Center (VICC), Benjamin F. Byrd Jr. Professor of Oncology and Executive Vice President for Research for Vanderbilt University Medical Center, is stepping down on June 30 from her long-held role as the Cancer Center’s director to focus on a combined leadership role… Read MoreFeb. 10, 2022